Financials

News Discussions Technicals Seasonals

STABL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Stayble Therapeutics AB engages in the development of pharmaceutical products. It develops an injectable treatment against chronic low back pain triggered by disc degeneration. The company was founded by Kjell Olmarker, Mattias Münnich, and Andreas Gerward in 2015 and is headquartered in Gothenburg, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

STABL has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company